|
Domestic medical device makers seek
hike in basic custom duty
The government needs to increase the basic customs duty on
medical devices in the range of 5-15 per cent to promote domestic manufacturing,
Association of Indian Medical Device Industry (AiMeD) said today.
The current slab is 0-7.5 per cent, it said. "The government
has rightly revised custom duty on Electronics to up to 20 per cent recently to
maintain the investment climate, and same is sought for Medical Electronics
where import dependency is 90 per cent," AiMeD Forum Coordinator Rajiv Nath told
PTI.
He said nominal import duty on critical items is not
protectionism but sound 'Make in India' economics.
The industry body urged the government to introspect as to
why, even after three years of the 'Make in India' campaign, the medical device
manufacturing is still floundering.
On its expectations from the Union Budget (2018-19), AiMeD
said the medical devices sector expects, "extension of inverted duty tariff
rationalisation to medical electronics & diagnostics". It also urged the
government to expedite buy Indian policy drafted by Department of
Pharmaceuticals which is pending with Ministry of Health & Family Welfare.
AiMeD also asked the Department of Pharmaceuticals to
accelerate trade margin capping proposal in the range of 50- 100 per cent,
depending on the cost of the devices.
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/domestic-medical-device-makers-seek-hikein-basic-custom-duty/articleshow/62458778.cms
***************************************************************
PolyOne to Begin Thermoplastic Elastomer
Production in India
PolyOne Corporation (NYSE: POL) today announced it expects to
begin production of thermoplastic elastomers (TPEs) this summer at its existing
facility in Pune, India. PolyOne currently produces color and additive
concentrates and engineered polymer solutions at the Pune facility. Adding TPE
production enables the company to support customers in the country even more
quickly and with a broader portfolio of domestically manufactured materials.
“This investment at our facility in Pune answers customers’
desire for a domestic supplier able to offer expertise in color, engineered
materials and thermoplastic elastomers,” said Craig Nikrant, president,
Specialty Engineered Materials, PolyOne. “We are the only global company to
offer all of these domestically produced materials in India. Customers benefit
from shorter lead times due to domestic production, and also from our global
network of polymer science expertise.”
https://plastics.com/plastic-news-business-materials-polyonebegin-thermoplastic-elastomer-production-india/
***************************************************************
Inauguration of Clariant's new
healthcare packaging plant in Cuddalore, Tamil Nadu
Clariant in India has established its eminence in the
specialty chemicals sector, with its presence in the country for more than 50
years. Clariant in India is living the “Make in India” mantra, and has built a
manufacturing hub for both exports and domestic markets. It comprises 11
production sites spread across Maharashtra, Gujarat, Madhya Pradesh, Tamil Nadu
and Telangana. Clariant in India aims for accelerated growth in the Indian
market through the six business units i.e. Masterbatches, Pigments, Additives,
Industrial & Consumer Specialties, Catalysts and Functional Minerals.
Adnan Ahmad, Region Head, Clariant in India said, “Clariant
is ambitious in India and we look to create a material and profitable specialty
chemical business through our new greenfield plant for healthcare packaging.
While this plant may not fall in the specialty chemicals category in the
traditional sense, but it is certainly a differentiated product offering. In
India, Business Line Medical Specialties has grown over the past few years and
this facility will give us clear edge against the competition.”
Ketan Premani, India Head of Business Unit - Medical
Specialties said, “Our new greenfield healthcare packaging production plant,
technology-wise is ‘state-of-the-art’. It is the first and so far the only ISO-8
clean room facility in the group and particularly in emerging markets of the
world. The facility will offer Desiccants and link our customers to Clariant's
global packaging design capabilities. Pharmaceutical regulatory compliance and
consistent quality is the hallmark of our offerings to the customers”
http://www.plastemart.com/news-plastics-information/inauguration-of-clariants-new-healthcare-packaging-plant-in-cuddaloretamil-nadu-/48375
|
